Skip to main content

Six Mainframe DevOps Predictions for 2023

predictions IBM Embracing the Power of the Mainframe with Deloitte

predictions IBM Embracing the Power of the Mainframe with DeloitteDevOps, or the automation of application development and hand-off to operations, is more prevalent than ever on the mainframe. As we begin 2023, below are six predictions for what the coming year will bring. The composite themes will undoubtedly be speed, alignment and experience. 1. Enterprise DevOps Will Break Down Silos Across Core Systems DevOps […]

The post Six Mainframe DevOps Predictions for 2023 appeared first on DevOps.com.



from DevOps.com https://ift.tt/Edo1tXL

Comments

Popular posts from this blog

Say Goodbye to Late-Night SRE Wake-Up Calls

Thousands of SREs, on-call engineers and DevOps pros all over the world dread nothing more than the late-night incident alert. The pager buzzing at 2:00 a.m. can cause panic for SREs and leave IT and DevOps teams with quite a mess to contain. But incident response doesn’t have to cause panic if you have the […] The post Say Goodbye to Late-Night SRE Wake-Up Calls appeared first on DevOps.com . from DevOps.com https://ift.tt/3lWJ92k

As Virus Cases Surge, Biden Administration Encourages More Use of Antibody Treatments

As Virus Cases Surge, Biden Administration Encourages More Use of Antibody Treatments By Noah Weiland and Rebecca Robbins from NYT U.S. https://ift.tt/3fUcEOX Coronavirus (2019-nCoV), Preventive Medicine, Drugs (Pharmaceuticals), Antibodies, Vaccination and Immunization, Regeneron Pharmaceuticals Inc, Eli Lilly and Company, Food and Drug Administration, Health and Human Services Department